Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Related Posts
FTX founder Bankman-Fried ‘on bread and water’ in jain, lawyers claim Sixth Amendment violation
Sam Bankman-Fried, the 31-year-old founder of the bankrupt FTX cryptocurrency exchange, pleaded not guilty to a fresh indictment…
Dogecoin (DOGE) to Match its ATH? Here’s What Could Spark the Surge
TL;DR A popular analyst suggests that if Dogecoin (DOGE) closes April above $0.20, it might ignite strong bullish…
Crypto Trading Volume Up 19% in July After Four-Month Decline: CCData
In July, global crypto trading volume on centralized exchanges surged by 19%, reaching $4.94 trillion. This marks the…